Mode
Text Size
Log in / Sign up
N/A N=25 Screening

A Pharmacist Intervention to Improve Mother and Child Health

Hypertension

Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Number of Participants Who Talk to Research Pharmacist — 20 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Research Pharmacist (Behavioral)
Age
Adult · 18+ yrs
Sex
Female
Sponsor
University of Iowa
Primary completion
Jul 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Who Talk to Research Pharmacist
20
PRIMARY
Number of Participants Who Return BP Measurements
22
PRIMARY
Percentage of Well-Child Visits Attended
57
PRIMARY
Percentage of Vaccinations Received
251
SECONDARY
Number of BP Measurements Submitted
12.9
SECONDARY
Blood Pressure Control
12
SECONDARY
Number of Participants Satisfied With the Study
7

Summary

The goal of this clinical trial is to learn if a research pharmacist can improve the health of new mothers and their babies. The main questions it aims to answer are: * Will postpartum women who had elevated blood pressure during pregnancy be willing to participate in the study, talk to a pharmacist about their health and the health of their child, and text us their blood pressure measurements? * Will contact with the pharmacist improve the health of the mother and/or the child? Participants will: * complete a baseline demographic survey, * be given a blood pressure cuff and taught how to use it, * be asked to text us their blood pressure values 2 times per day for 7 days after enrollment, * complete a phone call with a pharmacist discussing their health and the health of their baby, * text us their blood pressure 1 time per day for 3 days 1 month after enrollment, * have a 1 month follow-up phone call with the research pharmacist, and * complete an exit survey to provide feedback about the study.

Eligibility Criteria

Inclusion Criteria

  • biological mother of a baby attending a 1-week to 6-month well-child visit,
  • received prenatal care at University of Iowa Hospitals and Clinics,
  • had at least 2 elevated blood pressures (>= 130 mmHg systolic or >= 80 mmHg diastolic) during pregnancy,
  • owns a smartphone

Exclusion Criteria

  • arm circumference > 17 inches,
  • prisoner status
  • unable to provide own written informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06073054). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search